The transition from writing to programming regulatory submissions represents one of the most significant efficiency ...

For AI to be transformative in the pharmaceutical industry, it must be designed with a security-first approach. This means ...

Finding a conversation about AI at a conference like BIO 2025 is easy. But making those conversations meaningful and asking ...

The CGM is based on magnetohydrodynamic (MHD) technology, which non-invasively samples interstitial fluid, the body fluid ...

Basel-based BioVersys stands to receive CHF 5 million upfront under the terms of the deal, which could be worth up to CHF 479 ...

According to the government, the passport will eliminate multiple compliance assessments, reducing duplication across the ...

AstraZeneca chief executive Pascal Soriot is considering moving the company's stock exchange listing from the UK to the US – ...

The One Big Beautiful Bill (BBB), which passed (PDF) by a 51-50 vote with Vice President JD Vance casting the tie-breaker, ...

The 7th Exosome-Based Therapeutics Development Summit with never-before-seen data, covering the end-to-end from discovery ...

MSD's oral HIF-2 alpha inhibitor Welireg has a third FDA approval, becoming the first oral treatment for a rare form of solid tumour that affects around 2,000 people in the US each year.

Christoph: Historically, medical teams have lacked strategic priority, and technological capabilities needed for informed decision-making.Measuring impact can help medical affairs teams gather ...

The Veeva Commercial Summit 2024 explores the next-generation mindset that is shaping the future of the commercial sector. Get insights, network, and stay ahead of the curve with this overview of ...